Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$0.12 - $1.3 $58,704 - $635,962
-489,202 Reduced 98.62%
6,842 $0
Q3 2022

Oct 13, 2022

SELL
$0.17 - $0.26 $1,164 - $1,780
-6,849 Reduced 1.36%
496,044 $85,000
Q2 2022

Jul 28, 2022

BUY
$0.2 - $0.61 $54,198 - $165,303
270,990 Added 116.85%
502,893 $104,000
Q1 2022

May 05, 2022

BUY
$0.48 - $0.74 $28,957 - $44,642
60,328 Added 35.16%
231,903 $143,000
Q4 2021

Jan 24, 2022

BUY
$0.7 - $1.94 $120,102 - $332,855
171,575 New
171,575 $120,000

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.